Semaglutide (GLP1S)
For Research Use Only
Injectable
A GLP-1 receptor agonist that mimics the body's own after-meal hormone signal, slowing digestion and telling the brain "I'm full." It supports healthy appetite regulation and blood sugar balance by prompting insulin release only when blood sugar is already elevated, which is part of why it carries a lower hypoglycemia risk than older insulin-stimulating medications. Semaglutide is backed by more large-scale human clinical trial data than almost any other compound on this menu. Commonly used for: steady, sustainable appetite control and weight loss
Size: 20mg
$350.00
In stockCheckout opens once payment is connected.
Certificates of analysis
No certificate has been published for this product yet.
Research guides
- Semaglutide and the GLP-1 Receptor: What Binding and Receptor-Engagement Assays ReportA research-library survey of published structural, radioligand competition, cell-based signalling, and albumin-binding assay work in which semaglutide was characterised or used as a comparator at the GLP-1 receptor, with the model system (in vitro, animal, or human) stated for each finding.
This product is not for human or animal consumption. Misuse of this product is illegal.